CLASS II ONGOING Device recall · Reported 23 Nov 2022 · FDA Enforcement Report

TufTex Embolectomy Catheter recalled by LeMaitre Vascular

LeMaitre Vascular is recalling TufTex Embolectomy Catheter. The recall was initiated on 30 Sep 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots XSL0097, XSL0098, and XSL0099
Quantity recalled72 (OUS only)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0228-2023
FDA event ID
91006
Recalling firm
LeMaitre Vascular, Burlington, MA
Classification
Class II
Status
Ongoing
Recall initiated
30 Sep 2022
FDA classified
11 Nov 2022
Reported
23 Nov 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

30 Sep 2022Recall initiated by company
11 Nov 2022Classified by FDA+42 days
23 Nov 2022Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Three lots tied by two trainees were released without performing the required pull test. If tied with inadequate strength, the proximal ligature could slip toward the tip of the catheter and block the inflation hole, leading to the risk of the tip breaking off, and potentially becoming lost in the blood vessel.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

TufTex Embolectomy Catheter, Model No. This catheter has a latex balloon and a single lumen extrusion. It is inserted using a guidewire or introducer. The devices affected by this recall are 3F and 4F..

Where it was distributed

No US distribution. Foreign distribution to United Kingdom, Germany, France, Sweden, Austria, and Italy.

Questions about this recall

Why was it recalled?

Three lots tied by two trainees were released without performing the required pull test. If tied with inadequate strength, the proximal ligature could slip toward the tip of the catheter and block the inflation hole, leading to the risk of the tip breaking off, and potentially becoming lost in the blood vessel.

Which lots are affected?

Lots XSL0097, XSL0098, and XSL0099

Where was it sold?

No US distribution. Foreign distribution to United Kingdom, Germany, France, Sweden, Austria, and Italy.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from LeMaitre Vascular

All 71

Other Heart & Vascular Devices recalls

All 6,220